CONTR 2026 260564 CBAM-1 EXP AMC 2210/2025 (1326/2025 SUM NIRSEVIMAB)
Deadline:N/A
Your privacy is important to us
We use cookies to improve your experience and evaluate each item on our site. By clicking further, you accept our use of cookies.
We use cookies to improve your experience and evaluate each item on our site. By clicking further, you accept our use of cookies.